These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34359327)

  • 21. High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions.
    Fei X; Han P; Jiang B; Zhu L; Tian W; Sang M; Zhang X; Zhu Y; Luo Y
    J Clin Transl Hepatol; 2022 Feb; 10(1):26-33. PubMed ID: 35233370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
    Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
    Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis.
    Wan C; Du J; Fang H; Li F; Wang L
    Eur J Radiol; 2012 Apr; 81(4):e444-50. PubMed ID: 21612882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
    Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
    Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
    D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
    J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies.
    Pschierer K; Grothues D; Rennert J; da Silva NP; Schreyer AG; Melter M; Stroszczysnski C; Jung EM
    Clin Hemorheol Microcirc; 2015; 61(2):333-45. PubMed ID: 26444615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
    Du YR; Wu Y; Chen M; Gu XG
    Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation-Results from a Prospective Single-Center Study.
    Tufano A; Drudi FM; Angelini F; Polito E; Martino M; Granata A; Di Pierro GB; Kutrolli E; Sampalmieri M; Canale V; Flammia RS; Fresilli D; Bertolotto M; Leonardo C; Franco G; Cantisani V
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
    Quaia E
    Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
    Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
    Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study.
    Poanta L; Serban O; Pascu I; Pop S; Cosgarea M; Fodor D
    Med Ultrason; 2014 Mar; 16(1):7-14. PubMed ID: 24567918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?
    Dai Y; Chen MH; Yin SS; Yan K; Fan ZH; Wu W; Wang YB; Yang W
    Invest Radiol; 2007 Aug; 42(8):596-603. PubMed ID: 17620943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas - results of a Romanian multicentre study.
    Sirli R; Sporea I; Săndulescu DL; Popescu A; Dănilă M; Săftoiu A; Spârchez Z; Badea R
    Med Ultrason; 2015 Dec; 17(4):444-50. PubMed ID: 26649337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules.
    Li CY; Gong HY; Ling LJ; Du LW; Su T; Wang S; Wang J
    J Biomed Res; 2018 Jun; 32(3):198-207. PubMed ID: 29921747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.